Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania

Background - Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncomplicated Plasmodium falciparum malaria in many African countries. Nevertheless, the response of parasites to SP treatment has shown significant variation between individuals. Methods - The genes for dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) were used as markers, to investigate parasite resistance to SP in 141 children aged less than 5 years. Parasite DNA was extracted by Chelex method from blood samples collected and preserved on filter papers. Subsequently, polymerase chain reaction (PCR) and restriction fragment length polymorphism (PCR-RFLP) were applied to detect the SP resistance-associated point mutations on dhfr and dhps. Commonly reported point mutations at codons 51, 59, 108 and 164 in the dhfr and codons 437, 540 and 581 in the dhps domains were examined. Results - Children infected with parasites harbouring a range of single to quintuple dhfr/dhps mutations were erratically cured with SP. However, the quintuple dhfr/dhps mutant genotypes were mostly associated with treatment failures. High proportion of SP resistance-associated point mutations was detected in this study but the adequate clinical response (89.4%) observed clinically at day 14 of follow up reflects the role of semi-immunity protection and parasite clearance in the population. Conclusion - In monitoring drug resistance to SP, concurrent studies on possible confounding factors pertaining to development of resistance in falciparum malaria should be considered. The SP resistance potential detected in this study, cautions on its useful therapeutic life as an interim first-line drug against malaria in Tanzania and other malaria-endemic countries

Saved in:
Bibliographic Details
Main Authors: Mbugi, E.V., Mutayoba, B.M., Malisa, A.L., Balthazary, S.T., Nyambo, T.B., Mshinda, H.
Format: Article/Letter to editor biblioteca
Language:English
Subjects:antifolate resistance, chlorproguanil-dapsone, dihydrofolate-reductase, dihydropteroate-synthetase genes, in-vivo, molecular markers, mutations, proguanil resistance, synthase, treatment failure,
Online Access:https://research.wur.nl/en/publications/drug-resistance-to-sulphadoxine-pyrimethamine-in-plasmodium-falci
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-wur-nl-wurpubs-371661
record_format koha
spelling dig-wur-nl-wurpubs-3716612024-12-04 Mbugi, E.V. Mutayoba, B.M. Malisa, A.L. Balthazary, S.T. Nyambo, T.B. Mshinda, H. Article/Letter to editor Malaria Journal 5 (2006) ISSN: 1475-2875 Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania 2006 Background - Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncomplicated Plasmodium falciparum malaria in many African countries. Nevertheless, the response of parasites to SP treatment has shown significant variation between individuals. Methods - The genes for dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) were used as markers, to investigate parasite resistance to SP in 141 children aged less than 5 years. Parasite DNA was extracted by Chelex method from blood samples collected and preserved on filter papers. Subsequently, polymerase chain reaction (PCR) and restriction fragment length polymorphism (PCR-RFLP) were applied to detect the SP resistance-associated point mutations on dhfr and dhps. Commonly reported point mutations at codons 51, 59, 108 and 164 in the dhfr and codons 437, 540 and 581 in the dhps domains were examined. Results - Children infected with parasites harbouring a range of single to quintuple dhfr/dhps mutations were erratically cured with SP. However, the quintuple dhfr/dhps mutant genotypes were mostly associated with treatment failures. High proportion of SP resistance-associated point mutations was detected in this study but the adequate clinical response (89.4%) observed clinically at day 14 of follow up reflects the role of semi-immunity protection and parasite clearance in the population. Conclusion - In monitoring drug resistance to SP, concurrent studies on possible confounding factors pertaining to development of resistance in falciparum malaria should be considered. The SP resistance potential detected in this study, cautions on its useful therapeutic life as an interim first-line drug against malaria in Tanzania and other malaria-endemic countries en application/pdf https://research.wur.nl/en/publications/drug-resistance-to-sulphadoxine-pyrimethamine-in-plasmodium-falci 10.1186/1475-2875-5-94 https://edepot.wur.nl/33158 antifolate resistance chlorproguanil-dapsone dihydrofolate-reductase dihydropteroate-synthetase genes in-vivo molecular markers mutations proguanil resistance synthase treatment failure Wageningen University & Research
institution WUR NL
collection DSpace
country Países bajos
countrycode NL
component Bibliográfico
access En linea
databasecode dig-wur-nl
tag biblioteca
region Europa del Oeste
libraryname WUR Library Netherlands
language English
topic antifolate resistance
chlorproguanil-dapsone
dihydrofolate-reductase
dihydropteroate-synthetase genes
in-vivo
molecular markers
mutations
proguanil resistance
synthase
treatment failure
antifolate resistance
chlorproguanil-dapsone
dihydrofolate-reductase
dihydropteroate-synthetase genes
in-vivo
molecular markers
mutations
proguanil resistance
synthase
treatment failure
spellingShingle antifolate resistance
chlorproguanil-dapsone
dihydrofolate-reductase
dihydropteroate-synthetase genes
in-vivo
molecular markers
mutations
proguanil resistance
synthase
treatment failure
antifolate resistance
chlorproguanil-dapsone
dihydrofolate-reductase
dihydropteroate-synthetase genes
in-vivo
molecular markers
mutations
proguanil resistance
synthase
treatment failure
Mbugi, E.V.
Mutayoba, B.M.
Malisa, A.L.
Balthazary, S.T.
Nyambo, T.B.
Mshinda, H.
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
description Background - Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncomplicated Plasmodium falciparum malaria in many African countries. Nevertheless, the response of parasites to SP treatment has shown significant variation between individuals. Methods - The genes for dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) were used as markers, to investigate parasite resistance to SP in 141 children aged less than 5 years. Parasite DNA was extracted by Chelex method from blood samples collected and preserved on filter papers. Subsequently, polymerase chain reaction (PCR) and restriction fragment length polymorphism (PCR-RFLP) were applied to detect the SP resistance-associated point mutations on dhfr and dhps. Commonly reported point mutations at codons 51, 59, 108 and 164 in the dhfr and codons 437, 540 and 581 in the dhps domains were examined. Results - Children infected with parasites harbouring a range of single to quintuple dhfr/dhps mutations were erratically cured with SP. However, the quintuple dhfr/dhps mutant genotypes were mostly associated with treatment failures. High proportion of SP resistance-associated point mutations was detected in this study but the adequate clinical response (89.4%) observed clinically at day 14 of follow up reflects the role of semi-immunity protection and parasite clearance in the population. Conclusion - In monitoring drug resistance to SP, concurrent studies on possible confounding factors pertaining to development of resistance in falciparum malaria should be considered. The SP resistance potential detected in this study, cautions on its useful therapeutic life as an interim first-line drug against malaria in Tanzania and other malaria-endemic countries
format Article/Letter to editor
topic_facet antifolate resistance
chlorproguanil-dapsone
dihydrofolate-reductase
dihydropteroate-synthetase genes
in-vivo
molecular markers
mutations
proguanil resistance
synthase
treatment failure
author Mbugi, E.V.
Mutayoba, B.M.
Malisa, A.L.
Balthazary, S.T.
Nyambo, T.B.
Mshinda, H.
author_facet Mbugi, E.V.
Mutayoba, B.M.
Malisa, A.L.
Balthazary, S.T.
Nyambo, T.B.
Mshinda, H.
author_sort Mbugi, E.V.
title Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
title_short Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
title_full Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
title_fullStr Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
title_full_unstemmed Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
title_sort drug resistance to sulphadoxine-pyrimethamine in plasmodium falciparum malaria in mlimba, tanzania
url https://research.wur.nl/en/publications/drug-resistance-to-sulphadoxine-pyrimethamine-in-plasmodium-falci
work_keys_str_mv AT mbugiev drugresistancetosulphadoxinepyrimethamineinplasmodiumfalciparummalariainmlimbatanzania
AT mutayobabm drugresistancetosulphadoxinepyrimethamineinplasmodiumfalciparummalariainmlimbatanzania
AT malisaal drugresistancetosulphadoxinepyrimethamineinplasmodiumfalciparummalariainmlimbatanzania
AT balthazaryst drugresistancetosulphadoxinepyrimethamineinplasmodiumfalciparummalariainmlimbatanzania
AT nyambotb drugresistancetosulphadoxinepyrimethamineinplasmodiumfalciparummalariainmlimbatanzania
AT mshindah drugresistancetosulphadoxinepyrimethamineinplasmodiumfalciparummalariainmlimbatanzania
_version_ 1819150987000020992